Pharmaceutical product for the treatment of immunoregulatory...

Details Pharmaceutical product for the treatment of immunoregulatory... Pharmaceutical product for the treatment of immunoregulatory...

A - Human Necessities

61

K

167/139

A61K 39/395 (2006.01) C07K 16/24 (2006.01)

Patent

CA 2011893

Pharmaceutical Product for the Treatment of Immunoregulatory Disorders Abstract of the Disclosure A pharmaceutical product comprises an antibody to tumour necrosis factor and an antibody to interferon-.gamma. as a combined preparation for simultaneous separate or sequential use. The product is particularly suitable for treating immunoregulatory disorder such as organ transplant rejection or graft rejection. While antibody to tumour necrosis factor or antibody to interferon-.gamma. alone have little or no effect on rejection, the combination of antibodies produces a surprising prolongation of graft or transplant survival.

Affiliated with

Also associated with

Rating

Pharmaceutical product for the treatment of immunoregulatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical product for the treatment of immunoregulatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical product for the treatment of immunoregulatory... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1776121